- Home
- RADX vs BOWN Comparison
RADX vs BOWN Comparison
Compare RADX & BOWN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RADX
- BOWN
- Stock Information
- Founded
- RADX 2021
- BOWN 2023
- Country
- RADX Australia
- BOWN United States
- Employees
- RADX N/A
- BOWN N/A
- Industry
- RADX
- BOWN
- Sector
- RADX
- BOWN
- Exchange
- RADX NYSE
- BOWN Nasdaq
- Market Cap
- RADX 32.5M
- BOWN 28.5M
- IPO Year
- RADX N/A
- BOWN 2023
- Fundamental
- Price
- RADX $4.30
- BOWN N/A
- Analyst Decision
- RADX Strong Buy
- BOWN
- Analyst Count
- RADX 2
- BOWN 0
- Target Price
- RADX $13.50
- BOWN N/A
- AVG Volume (30 Days)
- RADX 21.6K
- BOWN 2.6K
- Earning Date
- RADX 02-26-2025
- BOWN 01-01-0001
- Dividend Yield
- RADX N/A
- BOWN N/A
- EPS Growth
- RADX N/A
- BOWN N/A
- EPS
- RADX N/A
- BOWN 0.02
- Revenue
- RADX $204,609.00
- BOWN N/A
- Revenue This Year
- RADX N/A
- BOWN N/A
- Revenue Next Year
- RADX N/A
- BOWN N/A
- P/E Ratio
- RADX N/A
- BOWN $206.51
- Revenue Growth
- RADX N/A
- BOWN N/A
- 52 Week Low
- RADX $3.50
- BOWN $2.71
- 52 Week High
- RADX $50.82
- BOWN $19.77
- Technical
- Relative Strength Index (RSI)
- RADX N/A
- BOWN 49.69
- Support Level
- RADX N/A
- BOWN $8.70
- Resistance Level
- RADX N/A
- BOWN $10.20
- Average True Range (ATR)
- RADX 0.00
- BOWN 0.42
- MACD
- RADX 0.00
- BOWN 0.04
- Stochastic Oscillator
- RADX 0.00
- BOWN 79.04
About RADX RADIOPHARM THERANOSTICS LIMITED SPON ADS EACH REP 300 ORD
Radiopharm Theranostics Ltd is an Australian based clinical-stage radiotherapeutics company which is targeting cancer. The company has a pipeline of around four licensed platform technologies, with diagnostic and therapeutic applications in both pre-clinical and clinical stages of development. The company is engaged in research, development and commercialization of health technologies.
About BOWN Bowen Acquisition Corp
Bowen Acquisition Corp is a blank check company.